Evidence map›Paper›PMID 39799847›Full record

ArticleDrug and alcohol dependence2025

Opioid use disorder prevalence in 57 New York counties from 2017 to 2019: A Bayesian evidence synthesis.

Tian Zheng, Katherine Keyes, Shouxuan Ji, Anna Calderon, Elwin Wu, Nathan J Doogan, Jennifer Villani, Redonna Chandler, Joshua A Barocas, Trang Nguyen and 2 more

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tian ZhengColumbia University, Department of Statistics, United States.
Katherine KeyesColumbia University Mailman School of Public Health, Department of Epidemiology, United States. Electronic address: kmk2104@columbia.edu.
Shouxuan JiColumbia University, Department of Statistics, United States.
Anna CalderonUniversity of Miami Miller School of Medicine, Department of Public Health Sciences, United States.
Elwin WuColumbia University School of Social Work, United States.
Nathan J DooganThe Ohio State University, Ohio Colleges of Medicine Government Resource Center, United States.
Jennifer VillaniNational Institute on Drug Abuse, United States.
Redonna ChandlerNational Institute on Drug Abuse, United States.
Joshua A BarocasUniversity of Colorado School of Medicine, Divisions of General Internal Medicine and Infectious Diseases, United States.
Trang NguyenNew York State Department of Public Health, United States.
Nabila El-BasselColumbia University School of Social Work, United States.
Daniel J FeasterUniversity of Miami Miller School of Medicine, Department of Public Health Sciences, United States.

Funding

MassHEAL - Reducing overdose deaths by 40% (2019-2023)UM1DA049412 · NIDA · BOSTON MEDICAL CENTER · PI SAMET, JEFFREY H. · 2019 to 2023
$82.9M
CHASE: An Innovative County-Level Public Health Response to the Opioid Epidemic in New York StateUM1DA049415 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, GILBERT, LOUISA · 2019 to 2023
$77.3M
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity SupplementUM1DA049417 · NIDA · OHIO STATE UNIVERSITY · PI FREISTHLER, BRIDGET J, WINHUSEN, T JOHN · 2019 to 2023
$66.3M
Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Development of a novel community-based high-performance surveillance network for drug useDP2DA051864 · NIDA · UNIVERSITY OF COLORADO DENVER · PI BAROCAS, JOSHUA ADAM · 2020 to 2020
$2.3M
NIDA NIH HHS DP2 DA051864NIDA NIH HHS T32 DA037801NIDA NIH HHS UM1 DA049412NIDA NIH HHS UM1 DA049415NIDA NIH HHS UM1 DA049417
6 · The paper itself

Abstract

introductionPrevalence estimates of opioid use disorder (OUD) at local levels are critical for public health planning and surveillance, yet largely unavailable across the US especially at the local county level.

methodsWe used a Bayesian evidence synthesis approach to estimate the prevalence of OUD for 57 counties across New York State for 2017-2019 and compare rates of OUD across counties as well as assess the extent of undiagnosed OUD. We developed a generative model to assess conditional probabilistic relations between different subgroups of the OUD population defined by diagnosis, treatment, and overdose fatality.

resultsAverage OUD prevalence from 2017 to 2019 ranged from 2.4 % (Westchester County) to 8.3 % (Sullivan County). Overall OUD prevalence estimates were relatively stable year to year, from 4.5 % in 2018 and 4.6 % in both 2017 and 2019. The Bayesian evidence synthesis estimate is consistently higher than the percentage diagnosed in Medicaid, by age and sex. By 2019, the estimated proportion of OUD that was undiagnosed ranged from 16.7 % in Clinton County to 62.7 % in Onondaga County. Counties with relatively high overdose death rates and low buprenorphine prescription percentages had the highest estimated level of undiagnosed OUD.

conclusionOUD prevalence varied considerably across the state. We identified counties with high OUD and overdose levels and a high proportion of undiagnosed OUD, providing insight into areas of the state in need of rapid expansion of services for people with OUD. Bayesian evidence synthesis approaches for OUD prevalence estimation represent a reliable and rigorous approach to providing local areas with information on OUD magnitude.

Indexed as

Opioid-Related DisordersAdolescentAdultBayes TheoremDrug OverdoseFemaleHumansMaleMiddle AgedNew YorkPrevalenceYoung AdultBayesian evidence synthesisOpioid use disorderPrevalence

Identifiers

PMID39799847
PMCPMC11977300

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.